Monopar Therapeutics SEC filings MNPR

Monopar Therapeutics has 536 filings in SEC EDGAR's recent list, going back to Jun 18, 2015. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Jun 22, 2026
DEFA14A Additional proxy material May 23, 2025 —
DEF 14A Proxy statement Apr 30, 2025 Jun 17, 2025
DEF 14A Proxy statement Jul 22, 2024 Aug 5, 2024
PRE 14A Preliminary proxy statement Jul 11, 2024 Aug 5, 2024
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 27, 2023
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 28, 2022
DEFA14A Additional proxy material May 3, 2021 —
DEF 14A Proxy statement Apr 30, 2021 Jun 30, 2021
DEFA14A Additional proxy material Apr 29, 2020 —
DEF 14A Proxy statement Apr 29, 2020 Jun 11, 2020
DEF 14C Information statement May 22, 2019 Jun 27, 2019
DEF 14C Information statement Apr 20, 2018 Jun 4, 2018

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MNPR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Wilmette, IL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1645469

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.